Melissa Hollo: Closing the Gap in Maternal Anemia Care Through HerCare
Melissa Hollo, Director of Project Management at hc1 and Licensed Independent Clinical Social Worker, shared a post on LinkedIn:
“Anemia in pregnancy is common, but its impact is often underestimated.
A recent UpToDate review by Michael Auerbach, Helain Landy and Thomas G. DeLoughery, highlights how untreated iron deficiency anemia can increase the risk of preterm birth, postpartum hemorrhage, and adverse outcomes for both mother and baby.
The challenge isn’t lack of testing, the signals often exist early in routine lab data.
The challenge is identifying those risks early enough to act.
That’s why we built HerCare: to analyze lab data, surface maternal risks earlier in pregnancy, and support clinicians with timely, guideline-informed insights.
Because improving maternal outcomes starts long before delivery.
Learn how we’re supporting earlier maternal risk detection.”
Stay updated with Hemostasis Today.
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy